Brittany Mueller, in Caledonia, WI - Social Worker

Brittany Mueller, is a Social Worker - Clinical based in Caledonia, Wisconsin. Brittany Mueller is licensed to practice in * (Not Available) (license number ) and her current practice location is 6430 County Road H, Caledonia, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (262) 977-0582.

NPI number for Brittany Mueller is 1164153201 and her current mailing address is 6430 County Road H, Caledonia, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1164153201.

Contact Information

	Brittany Mueller,
	6430 County Road H, Caledonia, WI 53108-9602
	(262) 977-0582
	Not Available

Healthcare Provider's Profile

Full Name	Brittany Mueller
Gender	Female
Speciality	Social Worker - Clinical
Location	6430 County Road H, Caledonia, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1164153201
Provider Enumeration Date: 06/20/2022
Last Update Date: 06/20/2022

Medical Identifiers

Medical identifiers for Brittany Mueller such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1164153201	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Brittany Mueller is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Brittany Mueller, 6430 County Road H, Caledonia, WI 53108-9602 Ph: (262) 977-0582	Brittany Mueller, 6430 County Road H, Caledonia, WI 53108-9602 Ph: (262) 977-0582

News Archive

Miniature brains that can move muscles, grown in the lab

Researchers have successfully created miniature organoid brains in the labs that when attached to a spinal cord and muscles could help move the muscles.

Allometric model shows human travel is closely related to spread of COVID-19

A new study indicates that the spread of COVID-19 is governed by power-law dynamics, suggesting that alternative modeling approaches need to be used to understand and predict its propagation.

ARHGEF28 gene mutations present in amyotrophic lateral sclerosis: Research

Researchers at Western University in London, Canada, have identified a new genetic mutation for amyotrophic lateral sclerosis (ALS), opening the door to future targeted therapies. Dr. Michael Strong, a scientist with Western's Robarts Research Institute and Distinguished University Professor in Clinical Neurological Sciences at the Schulich School of Medicine & Dentistry, and colleagues found that mutations within the ARHGEF28 gene are present in ALS.

EMA approves Shire's new REPLAGAL manufacturing facility in Lexington

Shire plc, the global specialty biopharmaceutical company, today announced that the European Medicines Agency has approved the purification of REPLAGAL® (agalsidase alfa) drug substance at its new manufacturing facility in Lexington, MA, US. REPLAGAL, Shire's enzyme replacement therapy for the treatment of Fabry disease is the first product that will be made available to patients from the new facility.

Brittany Mueller, - Clinical Social Worker in Caledonia, WI